| 1Amphetamine-d11 |
|---|
| 2Amphetamine |
| 3Methamphetamine-d14 |
| 4Methamphetamine |
| 5MDA-d5 |
| 6MDA |
| 7MDMA-d5 |
| 8MDMA |
| 9MDEA-d5 |
| 10MDEA |
search
Applications
Expanded amphetamines from urine by Screen C on a ZB-Drug1
18034
Separation Mode: Application Specific
Application Specific
ZB-Drug-1
GC
Serotonin Agents
Forensics/Toxicology
Toxicology / Drug Screening / TDM
Therapeutic / Clinical
Analytes
Details
GC Conditions (App ID: 18034)
Column: |
Part No: |
Phase Name: ZB-Drug-1 |
Sample Notes: Analytes are 500ng/mL in urine derivatized with HFBA
Sim ions:
(Quant ion*) D11-Amphetamine (*244,128): Amphetamine (*240,118,117): D14-Methamphetamine (*261,213): Methamphetamine (*254,210,118): D5-MDA (*167,380,244): MDA (*162,375,240): D5-MDMA (*258,213,164): MDMA (*254,210,389): D5-MDEA (*273,241,408): MDEA (*268,240,403) |
Similar Applications
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.